Cargando…

Antiviral Immune Response as a Trigger of FUS Proteinopathy in Amyotrophic Lateral Sclerosis

Mutations in the FUS gene cause familial amyotrophic lateral sclerosis (ALS-FUS). In ALS-FUS, FUS-positive inclusions are detected in the cytoplasm of neurons and glia, a condition known as FUS proteinopathy. Mutant FUS incorporates into stress granules (SGs) and can spontaneously form cytoplasmic R...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shelkovnikova, Tatyana A., An, Haiyan, Skelt, Lucy, Tregoning, John S., Humphreys, Ian R., Buchman, Vladimir L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cell Press 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6941233/ https://www.ncbi.nlm.nih.gov/pubmed/31875556 http://dx.doi.org/10.1016/j.celrep.2019.11.094

Ejemplares similares

ALS-linked FUS mutations confer loss and gain of function in the nucleus by promoting excessive formation of dysfunctional paraspeckles
por: An, Haiyan, et al.
Publicado: (2019)

Frameshift peptides alter the properties of truncated FUS proteins in ALS-FUS
por: An, Haiyan, et al.
Publicado: (2020)

Gamma-synuclein pathology in amyotrophic lateral sclerosis
por: Peters, Owen M, et al.
Publicado: (2015)

Protective paraspeckle hyper-assembly downstream of TDP-43 loss of function in amyotrophic lateral sclerosis
por: Shelkovnikova, Tatyana A., et al.
Publicado: (2018)

Post-Translational Modifications Modulate Proteinopathies of TDP-43, FUS and hnRNP-A/B in Amyotrophic Lateral Sclerosis
por: Farina, Stefania, et al.
Publicado: (2021)

Diverse roles of FUS in Amyotrophic Lateral Sclerosis
por: Carri, Maria Teresa, et al.
Publicado: (2015)

Calcium-responsive transactivator (CREST) protein shares a set of structural and functional traits with other proteins associated with amyotrophic lateral sclerosis
por: Kukharsky, Michail S, et al.
Publicado: (2015)

Fused in Sarcoma (FUS) Protein Lacking Nuclear Localization Signal (NLS) and Major RNA Binding Motifs Triggers Proteinopathy and Severe Motor Phenotype in Transgenic Mice
por: Shelkovnikova, Tatyana A., et al.
Publicado: (2013)

ALS-linked cytoplasmic FUS assemblies are compositionally different from physiological stress granules and sequester hnRNPA3, a novel modifier of FUS toxicity
por: An, Haiyan, et al.
Publicado: (2022)

Recruitment into stress granules prevents irreversible aggregation of FUS protein mislocalized to the cytoplasm
por: Shelkovnikova, Tatyana A, et al.
Publicado: (2013)

Association of Plasma Biomarkers for Angiogenesis and Proteinopathy in Indian Amyotrophic Lateral Sclerosis Patients
por: Modgil, Shweta, et al.
Publicado: (2020)

Distinct responses of neurons and astrocytes to TDP-43 proteinopathy in amyotrophic lateral sclerosis
por: Smethurst, Phillip, et al.
Publicado: (2020)

Selective pattern of motor system damage in gamma-synuclein transgenic mice mirrors the respective pathology in amyotrophic lateral sclerosis
por: Peters, Owen M., et al.
Publicado: (2012)

Dimebon Slows Progression of Proteinopathy in γ-Synuclein Transgenic Mice
por: Bachurin, Sergey O., et al.
Publicado: (2011)

Proteinopathies as Hallmarks of Impaired Gene Expression, Proteostasis and Mitochondrial Function in Amyotrophic Lateral Sclerosis
por: Benson, Bridget C., et al.
Publicado: (2021)

Connecting RNA-Modifying Similarities of TDP-43, FUS, and SOD1 with MicroRNA Dysregulation Amidst A Renewed Network Perspective of Amyotrophic Lateral Sclerosis Proteinopathy
por: Pham, Jade, et al.
Publicado: (2020)

Characterization of FUS Mutations in Amyotrophic Lateral Sclerosis Using RNA-Seq
por: van Blitterswijk, Marka, et al.
Publicado: (2013)

Widespread FUS mislocalization is a molecular hallmark of amyotrophic lateral sclerosis
por: Tyzack, Giulia E, et al.
Publicado: (2019)

Multistep process of FUS aggregation in the cell cytoplasm involves RNA-dependent and RNA-independent mechanisms
por: Shelkovnikova, Tatyana A., et al.
Publicado: (2014)

FUS and TARDBP but Not SOD1 Interact in Genetic Models of Amyotrophic Lateral Sclerosis
por: Kabashi, Edor, et al.
Publicado: (2011)

Amyotrophic Lateral Sclerosis associated FUS mutation shortens mitochondria and induces neurotoxicity
por: Nakaya, Tadashi, et al.
Publicado: (2018)

Phenotypes and malignancy risk of different FUS mutations in genetic amyotrophic lateral sclerosis
por: Naumann, Marcel, et al.
Publicado: (2019)

Possible Somatic Mosaicism of Novel FUS Variant in Familial Amyotrophic Lateral Sclerosis
por: Hisahara, Shin, et al.
Publicado: (2021)

Aberrant Localization of FUS and TDP43 Is Associated with Misfolding of SOD1 in Amyotrophic Lateral Sclerosis
por: Pokrishevsky, Edward, et al.
Publicado: (2012)

Defective cyclophilin A induces TDP-43 proteinopathy: implications for amyotrophic lateral sclerosis and frontotemporal dementia
por: Pasetto, Laura, et al.
Publicado: (2021)

FUS Transgenic Rats Develop the Phenotypes of Amyotrophic Lateral Sclerosis and Frontotemporal Lobar Degeneration
por: Huang, Cao, et al.
Publicado: (2011)

Amyotrophic lateral sclerosis-linked FUS/TLS alters stress granule assembly and dynamics
por: Baron, Desiree M, et al.
Publicado: (2013)

Yeast as a Model to Unravel Mechanisms Behind FUS Toxicity in Amyotrophic Lateral Sclerosis
por: Lindström, Michelle, et al.
Publicado: (2018)

Mutant FUS and ELAVL4 (HuD) Aberrant Crosstalk in Amyotrophic Lateral Sclerosis
por: De Santis, Riccardo, et al.
Publicado: (2019)

FUS P525L mutation causing amyotrophic lateral sclerosis and movement disorders
por: Zhou, Binbin, et al.
Publicado: (2020)

Antisense oligonucleotide silencing of FUS expression as a therapeutic approach in amyotrophic lateral sclerosis
por: Korobeynikov, Vladislav A., et al.
Publicado: (2022)

Co-Occurrence of Multiple Sclerosis and Amyotrophic Lateral Sclerosis in an FUS-Mutated Patient: A Case Report
por: Fiondella, Luigi, et al.
Publicado: (2022)

Aberrant interaction of FUS with the U1 snRNA provides a molecular mechanism of FUS induced amyotrophic lateral sclerosis
por: Jutzi, Daniel, et al.
Publicado: (2020)

Methodology Aspects of Colony Maintain for a Murine Model of Amyotrophic Lateral Sclerosis (ALS) TDP-43 Proteinopathy
por: Álvaro-Alonso, César, et al.
Publicado: (2020)

FUS/TLS deficiency causes behavioral and pathological abnormalities distinct from amyotrophic lateral sclerosis
por: Kino, Yoshihiro, et al.
Publicado: (2015)

Motor neuron intrinsic and extrinsic mechanisms contribute to the pathogenesis of FUS-associated amyotrophic lateral sclerosis
por: Scekic-Zahirovic, Jelena, et al.
Publicado: (2017)

Clinical and Genetic Features of Patients with Juvenile Amyotrophic Lateral Sclerosis with Fused in Sarcoma (FUS) Mutation
por: Yu, Xiaolong, et al.
Publicado: (2018)

FUS-mediated regulation of acetylcholine receptor transcription at neuromuscular junctions is compromised in amyotrophic lateral sclerosis
por: Picchiarelli, Gina, et al.
Publicado: (2019)

Clinical feature difference between juvenile amyotrophic lateral sclerosis with SPTLC1 and FUS mutations
por: Wang, Peishan, et al.
Publicado: (2023)

Intracellular localization and splicing regulation of FUS/TLS are variably affected by amyotrophic lateral sclerosis-linked mutations
por: Kino, Yoshihiro, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_1voochcmthjf5i179cttnei9co